Ajooni Biotech Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
AJOONI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Ajooni Biotech Limited's promoters and promoter group have submitted their yearly disclosure under SEBI regulation 31(4) for the financial year ended March 31, 2026. The disclosure confirms that neither the promoters nor persons acting in concert have created any encumbrance (pledge) over their shareholdings during the year. The promoter group includes Managing Director Jasjot Singh and promoter group members Parmjeet Kaur, Unneet Kaur, Ashmeet Kaur, and Ishneet Kaur. This is a routine regulatory compliance filing required to be submitted annually by listed companies.
The absence of any share pledging by promoters is generally a positive indicator for retail investors, as it reduces the risk of forced selling that could dilute stock value. This is a standard compliance filing with no immediate impact on stock price.